BDBM405257 5-(4-(6-acetamidopyridazin-3-yl) butyl)-N-((4-(trifluoromethyl) pyridin-2-yl)methyl)-1,3,4- thiadiazole-2-carboxamide::US10344025, Example 601::US11370786, Example 601

SMILES CC(=O)Nc1ccc(CCCCc2nnc(s2)C(=O)NCc2cc(ccn2)C(F)(F)F)nn1

InChI Key InChIKey=JSYUEHLCMBQNAT-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 405257   

TargetGlutaminase kidney isoform, mitochondrial(Human)
University Of Texas

US Patent
LigandPNGBDBM405257(5-(4-(6-acetamidopyridazin-3-yl) butyl)-N-((4-(tri...)
Affinity DataIC50: 100nMAssay Description:The inhibition of purified recombinant human GAC by varying concentrations of inhibitors is assessed via a dual-coupled enzymatic assay. The glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetGlutaminase kidney isoform, mitochondrial(Human)
University Of Texas

US Patent
LigandPNGBDBM405257(5-(4-(6-acetamidopyridazin-3-yl) butyl)-N-((4-(tri...)
Affinity DataIC50: 100nMAssay Description:The inhibition of purified recombinant human GAC by varying concentrations of inhibitors is assessed via a dual-coupled enzymatic assay. The glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2020
Entry Details
US Patent